M1-like MDSCs are characterized as tumor-inhibiting cells by the production of TNF-α, IL-12, and nitric oxide, whereas M2-type MDSCs thwart the tumoricidal effect of T lymphocytes or NK cells by secreting TGF-β, IL-10 and arginase [94]. The gene discussed is TNF; the disease is neoplasm.